The Evidence Base
Post
Understanding the role of RWD-based external controls in defining the long-term benefit–risk profile of cell and gene therapies: a multistakeholder perspective
Register with The Evidence Base for free to access this content
Already have an account? Sign in
By registering with The Evidence Base, you will receive our weekly round-up and other relevant editorial content. You can opt-out at any time. View our privacy policy here.